Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of the ...
Amazon Web Services (AWS) has announced the availability of Claude Sonnet 4.5 in Amazon Bedrock, which joins the existing Claude 4 models available to customers. These hybrid reasoning models (meaning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback